VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,907,603 | -11.0% | 70,888 | -0.4% | 1.74% | -7.3% |
| Q2 2023 | $2,142,710 | -22.9% | 71,163 | -17.2% | 1.87% | -22.2% |
| Q1 2023 | $2,780,183 | +104496.8% | 85,941 | -7.3% | 2.41% | +2.2% |
| Q4 2022 | $2,658 | -99.9% | 92,749 | -0.1% | 2.36% | +19.4% |
| Q3 2022 | $2,239,000 | -7.5% | 92,823 | +5.0% | 1.97% | -2.6% |
| Q2 2022 | $2,421,000 | -28.1% | 88,435 | +0.7% | 2.03% | -20.0% |
| Q1 2022 | $3,367,000 | +10.1% | 87,801 | -8.0% | 2.53% | +11.8% |
| Q4 2021 | $3,058,000 | +2.2% | 95,486 | -6.0% | 2.27% | +0.8% |
| Q3 2021 | $2,993,000 | -12.8% | 101,555 | +0.5% | 2.25% | -10.1% |
| Q2 2021 | $3,432,000 | – | 101,003 | – | 2.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |